Identification of Lipid Biomarkers for Chronic Joint Pain Associated with Different Joint Diseases.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
09 02 2023
Historique:
received: 02 01 2023
revised: 04 02 2023
accepted: 06 02 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

Lipids, especially lysophosphatidylcholine LPC16:0, have been shown to be involved in chronic joint pain through the activation of acid-sensing ion channels (ASIC3). The aim of the present study was to investigate the lipid contents of the synovial fluids from controls and patients suffering from chronic joint pain in order to identify characteristic lipid signatures associated with specific joint diseases. For this purpose, lipids were extracted from the synovial fluids and analyzed by mass spectrometry. Lipidomic analyses identified certain choline-containing lipid classes and molecular species as biomarkers of chronic joint pain, regardless of the pathology, with significantly higher levels detected in the patient samples. Moreover, correlations were observed between certain lipid levels and the type of joint pathologies. Interestingly, LPC16:0 levels appeared to correlate with the metabolic status of patients while other choline-containing lipids were more specifically associated with the inflammatory state. Overall, these data point at selective lipid species in synovial fluid as being strong predictors of specific joint pathologies which could help in the selection of the most adapted treatment.

Identifiants

pubmed: 36830710
pii: biom13020342
doi: 10.3390/biom13020342
pmc: PMC9953120
pii:
doi:

Substances chimiques

Lipids 0
Biomarkers 0

Banques de données

ClinicalTrials.gov
['NCT01867840']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Agence Nationale de la Recherche
ID : ANR-17-CE16-0018
Organisme : Association Française contre les Myopathies
ID : 23731
Organisme : Agence Nationale de la Recherche
ID : ANR-11-LABX-0015-01

Références

Arthritis Rheumatol. 2015 Jan;67(1):117-27
pubmed: 25303044
Nature. 1997 Mar 13;386(6621):173-7
pubmed: 9062189
Biochim Biophys Acta. 2011 Mar;1811(3):153-62
pubmed: 21146630
Life Sci. 2020 Apr 15;247:117443
pubmed: 32084434
J Lipid Res. 2008 Jan;49(1):84-97
pubmed: 17951222
Arthritis Rheum. 2013 Sep;65(9):2323-33
pubmed: 23784884
J Immunol. 2006 Apr 1;176(7):4369-74
pubmed: 16547275
Allergol Immunopathol (Madr). 2015 Jan-Feb;43(1):81-7
pubmed: 24656623
Inflamm Res. 2012 May;61(5):473-83
pubmed: 22252240
Eur J Pharmacol. 2009 Nov 10;622(1-3):58-64
pubmed: 19766625
Osteoarthritis Cartilage. 2016 Aug;24(8):1470-8
pubmed: 27049029
Cell Immunol. 2010;265(2):87-90
pubmed: 20832779
Biochim Biophys Acta. 2012 Sep;1822(9):1442-52
pubmed: 22627108
Biochim Biophys Acta. 2013 Jan;1831(1):42-60
pubmed: 22867755
Arthritis Rheum. 1962 Dec;5:589-601
pubmed: 13968590
Osteoarthritis Cartilage. 2020 Jan;28(1):45-52
pubmed: 31394191
J Biol Chem. 2007 Sep 14;282(37):27155-27164
pubmed: 17636253
J Biol Chem. 1957 May;226(1):497-509
pubmed: 13428781
Clin Chim Acta. 2012 Jan 18;413(1-2):303-7
pubmed: 22037510
EMBO J. 2016 Feb 15;35(4):414-28
pubmed: 26772186
Clin Orthop Relat Res. 2014 Dec;472(12):3997-4003
pubmed: 25070920
Metabolites. 2011 Dec 1;1(1):21-40
pubmed: 22905337
J Leukoc Biol. 1999 Oct;66(4):535-41
pubmed: 10534105
Arthritis Res Ther. 2009;11(2):R43
pubmed: 19296835
Ann Transl Med. 2016 Apr;4(7):133
pubmed: 27162783
Ann Rheum Dis. 1987 Oct;46(10):721-6
pubmed: 3120655
Biochem J. 1995 Feb 1;305 ( Pt 3):689-705
pubmed: 7848265
Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):88-93
pubmed: 18156367
Pain Med. 2019 Mar 1;20(3):464-475
pubmed: 29701812
PLoS One. 2014 Mar 19;9(3):e91769
pubmed: 24646942
EMBO Mol Med. 2010 May;2(5):172-87
pubmed: 20432503
Immunobiology. 2011 Jan-Feb;216(1-2):118-25
pubmed: 20655126
J Biol Chem. 2012 Dec 14;287(51):43116-25
pubmed: 23139417
Pain. 2022 Oct 1;163(10):1999-2013
pubmed: 35086123
Endocr Metab Immune Disord Drug Targets. 2008 Dec;8(4):231-7
pubmed: 19075776
Clin Vaccine Immunol. 2010 Mar;17(3):429-38
pubmed: 20071492
J Lipid Res. 2003 Apr;44(4):754-61
pubmed: 12562829
Int J Mol Sci. 2019 Mar 06;20(5):
pubmed: 30845751
EMBO J. 2008 Nov 19;27(22):3047-55
pubmed: 18923424
Ann Rheum Dis. 1996 Oct;55(10):695-7
pubmed: 8984932

Auteurs

Spiro Khoury (S)

Université de Poitiers, Laboratoire Lipotoxicity and Channelopathies (LiTch)-ConicMeds, 86073 Poitiers, France.

Jenny Colas (J)

Université de Poitiers, Laboratoire Lipotoxicity and Channelopathies (LiTch)-ConicMeds, 86073 Poitiers, France.
Université de Poitiers, Laboratoire PRéTI, 86073 Poitiers, France.

Véronique Breuil (V)

Université Côte d'Azur (UCA), UMR E-4320 MATOs CEA/iBEB/SBTN, Faculté de Médecine, CEDEX 2, 06107 Nice, France.
Service de Rhumatologie, Hôpital Pasteur, CHU de Nice, 06000 Nice, France.

Eva Kosek (E)

Department of Clinical Neuroscience, Karolinska Institutet, 17165 Solna, Sweden.
Department of Surgical Sciences, Uppsala University, 75185 Uppsala, Sweden.

Aisha S Ahmed (AS)

Department of Molecular Medicine and Surgery, Karolinska Institutet, 17176 Stockholm, Sweden.

Camilla I Svensson (CI)

Department of Physiology and Pharmacology, Center for Molecular Medicine, Karolinska Institutet, 17165 Solna, Sweden.

Fabien Marchand (F)

Université Clermont Auvergne, Inserm U1107 Neuro-Dol, Pharmacologie Fondamentale et Clinique de la Douleur, 63001 Clermont-Ferrand, France.

Emmanuel Deval (E)

Université Côte d'Azur, CNRS, IPMC, LabEx ICST, FHU InovPain, 06560 Valbonne, France.

Thierry Ferreira (T)

Université de Poitiers, Laboratoire Lipotoxicity and Channelopathies (LiTch)-ConicMeds, 86073 Poitiers, France.
Université de Poitiers, Laboratoire PRéTI, 86073 Poitiers, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH